Response to Cembrowski et al. regarding "Could susceptibility to low hematocrit interference have compromised the results of the NICE-SUGAR trial?"
Gespeichert in:
Veröffentlicht in: | Clinical chemistry (Baltimore, Md.) Md.), 2010-10, Vol.56 (10), p.1643; author reply 1643-1643 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1643 |
---|---|
container_issue | 10 |
container_start_page | 1643; author reply 1643 |
container_title | Clinical chemistry (Baltimore, Md.) |
container_volume | 56 |
creator | Mahoney, John J Maguire, Patricia Ellison, John M Cariski, Alan T |
description | |
doi_str_mv | 10.1373/clinchem.2010.150995 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_755972078</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>755972078</sourcerecordid><originalsourceid>FETCH-LOGICAL-c301t-1fe3d09fd7c3c6e44ac08c3f14df5bcdf6df2758765597556f3d0e9ab8a023093</originalsourceid><addsrcrecordid>eNo9UU1P3DAUtKqiskD_QVVZXHrKYsdxnJwQiiggoSLxcY4c-5l1ceKt7RTxO_qHcVjo6WmeZuaN3iD0jZI1ZYKdKGcntYFxXZJlxUnb8k9oRTkjRcNr-hmtCCFt0dJK7KODGH9nWImm_oL2S1KLTClX6N8txK2fIuDkcQfjEPxzfLIYEpZujQM8yqDt9IiPOz87jeMcFWyTHayz6WUROf-McwyZvAo2YTslCAYCTArwRv4FrPy4DX60ETROG8iecXYpYm_e4K-r7ry4e7g4u8UpWOlOj4_QnpEuwtf3eYgefp7fd5fF9c3FVXd2XShGaCqoAaZJa7RQTNVQVVKRRjFDK234oLSptSkFb0TNeSs4r02mQyuHRpKSkZYdoh873xzvzwwx9TmkAufkBH6OvVh0JRFNZlY7pgo-xgCm3wY7yvDSU9IvbfQfbfRLG_2ujSz7_n5gHkbQ_0Uf72ev8tiKQQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>755972078</pqid></control><display><type>article</type><title>Response to Cembrowski et al. regarding "Could susceptibility to low hematocrit interference have compromised the results of the NICE-SUGAR trial?"</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Mahoney, John J ; Maguire, Patricia ; Ellison, John M ; Cariski, Alan T</creator><creatorcontrib>Mahoney, John J ; Maguire, Patricia ; Ellison, John M ; Cariski, Alan T</creatorcontrib><identifier>ISSN: 0009-9147</identifier><identifier>EISSN: 1530-8561</identifier><identifier>DOI: 10.1373/clinchem.2010.150995</identifier><identifier>PMID: 20675612</identifier><language>eng</language><publisher>England</publisher><subject>Blood Glucose - analysis ; Critical Illness ; False Positive Reactions ; Hematocrit ; Humans ; Hypoglycemia - blood ; Hypoglycemia - diagnosis ; Intensive Care Units ; Monitoring, Physiologic - methods</subject><ispartof>Clinical chemistry (Baltimore, Md.), 2010-10, Vol.56 (10), p.1643; author reply 1643-1643</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c301t-1fe3d09fd7c3c6e44ac08c3f14df5bcdf6df2758765597556f3d0e9ab8a023093</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20675612$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mahoney, John J</creatorcontrib><creatorcontrib>Maguire, Patricia</creatorcontrib><creatorcontrib>Ellison, John M</creatorcontrib><creatorcontrib>Cariski, Alan T</creatorcontrib><title>Response to Cembrowski et al. regarding "Could susceptibility to low hematocrit interference have compromised the results of the NICE-SUGAR trial?"</title><title>Clinical chemistry (Baltimore, Md.)</title><addtitle>Clin Chem</addtitle><subject>Blood Glucose - analysis</subject><subject>Critical Illness</subject><subject>False Positive Reactions</subject><subject>Hematocrit</subject><subject>Humans</subject><subject>Hypoglycemia - blood</subject><subject>Hypoglycemia - diagnosis</subject><subject>Intensive Care Units</subject><subject>Monitoring, Physiologic - methods</subject><issn>0009-9147</issn><issn>1530-8561</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9UU1P3DAUtKqiskD_QVVZXHrKYsdxnJwQiiggoSLxcY4c-5l1ceKt7RTxO_qHcVjo6WmeZuaN3iD0jZI1ZYKdKGcntYFxXZJlxUnb8k9oRTkjRcNr-hmtCCFt0dJK7KODGH9nWImm_oL2S1KLTClX6N8txK2fIuDkcQfjEPxzfLIYEpZujQM8yqDt9IiPOz87jeMcFWyTHayz6WUROf-McwyZvAo2YTslCAYCTArwRv4FrPy4DX60ETROG8iecXYpYm_e4K-r7ry4e7g4u8UpWOlOj4_QnpEuwtf3eYgefp7fd5fF9c3FVXd2XShGaCqoAaZJa7RQTNVQVVKRRjFDK234oLSptSkFb0TNeSs4r02mQyuHRpKSkZYdoh873xzvzwwx9TmkAufkBH6OvVh0JRFNZlY7pgo-xgCm3wY7yvDSU9IvbfQfbfRLG_2ujSz7_n5gHkbQ_0Uf72ev8tiKQQ</recordid><startdate>201010</startdate><enddate>201010</enddate><creator>Mahoney, John J</creator><creator>Maguire, Patricia</creator><creator>Ellison, John M</creator><creator>Cariski, Alan T</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201010</creationdate><title>Response to Cembrowski et al. regarding "Could susceptibility to low hematocrit interference have compromised the results of the NICE-SUGAR trial?"</title><author>Mahoney, John J ; Maguire, Patricia ; Ellison, John M ; Cariski, Alan T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c301t-1fe3d09fd7c3c6e44ac08c3f14df5bcdf6df2758765597556f3d0e9ab8a023093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Blood Glucose - analysis</topic><topic>Critical Illness</topic><topic>False Positive Reactions</topic><topic>Hematocrit</topic><topic>Humans</topic><topic>Hypoglycemia - blood</topic><topic>Hypoglycemia - diagnosis</topic><topic>Intensive Care Units</topic><topic>Monitoring, Physiologic - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mahoney, John J</creatorcontrib><creatorcontrib>Maguire, Patricia</creatorcontrib><creatorcontrib>Ellison, John M</creatorcontrib><creatorcontrib>Cariski, Alan T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical chemistry (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mahoney, John J</au><au>Maguire, Patricia</au><au>Ellison, John M</au><au>Cariski, Alan T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Response to Cembrowski et al. regarding "Could susceptibility to low hematocrit interference have compromised the results of the NICE-SUGAR trial?"</atitle><jtitle>Clinical chemistry (Baltimore, Md.)</jtitle><addtitle>Clin Chem</addtitle><date>2010-10</date><risdate>2010</risdate><volume>56</volume><issue>10</issue><spage>1643; author reply 1643</spage><epage>1643</epage><pages>1643; author reply 1643-1643</pages><issn>0009-9147</issn><eissn>1530-8561</eissn><cop>England</cop><pmid>20675612</pmid><doi>10.1373/clinchem.2010.150995</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-9147 |
ispartof | Clinical chemistry (Baltimore, Md.), 2010-10, Vol.56 (10), p.1643; author reply 1643-1643 |
issn | 0009-9147 1530-8561 |
language | eng |
recordid | cdi_proquest_miscellaneous_755972078 |
source | MEDLINE; Oxford University Press Journals All Titles (1996-Current) |
subjects | Blood Glucose - analysis Critical Illness False Positive Reactions Hematocrit Humans Hypoglycemia - blood Hypoglycemia - diagnosis Intensive Care Units Monitoring, Physiologic - methods |
title | Response to Cembrowski et al. regarding "Could susceptibility to low hematocrit interference have compromised the results of the NICE-SUGAR trial?" |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T20%3A35%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Response%20to%20Cembrowski%20et%20al.%20regarding%20%22Could%20susceptibility%20to%20low%20hematocrit%20interference%20have%20compromised%20the%20results%20of%20the%20NICE-SUGAR%20trial?%22&rft.jtitle=Clinical%20chemistry%20(Baltimore,%20Md.)&rft.au=Mahoney,%20John%20J&rft.date=2010-10&rft.volume=56&rft.issue=10&rft.spage=1643;%20author%20reply%201643&rft.epage=1643&rft.pages=1643;%20author%20reply%201643-1643&rft.issn=0009-9147&rft.eissn=1530-8561&rft_id=info:doi/10.1373/clinchem.2010.150995&rft_dat=%3Cproquest_cross%3E755972078%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=755972078&rft_id=info:pmid/20675612&rfr_iscdi=true |